Some other key findings from the study are: - The increased risk of ASCVD was partly mediated by plasma levels of TMAO, gamma-butyrobetaine (GBB) and crotonobetaine (a proatherogenic gut microbiome metabolite of L-Carnitine)[20] - Insulin levels and blood glucose as well as systemic inflammation also contributed to the higher risk of ASCVD associated with meat intake - Blood pressure nor blood cholesterol levels were identified as contributors to the increased risk of ASCVD associated with meat intake - Intakes of fish, poultry, and eggs were not significantly associated with ASCVD
The two peptides are clinically synergistic. No controlled combination trial was identified
Meanwhile, electromyography, another traditional examination of PNP according to the latest guideline [14], was compared between ALC and placebo group in several studies [10, 2123], suggesting a significant improvement of both sensory and motor nerve conduction velocity after treatment of ALC
While supplementation with exogenous GSH has shown therapeutic potential on its own, recent findings indicate advantages to combined treatment with other immunomodulatory or anti-infective agents (Vairetti et al., 2021)
